AXON
VENTE TOTALE: 20 000 titres (~10 686 086,00 $ US)
- Insiders
- SMITH PATRICK W
- Total bought
- —
- Total sold
- $10,686,086
- Last activity
- 2026-09-08
- Last synced
-
2026-09-11 10:16:43
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-11
AXON presents a deeply unfavorable risk/reward profile: deteriorating fundamentals (EBIT/EBITDA margin compression, negative interest coverage) combine with an extremely weak catalyst score of 20 and no identifiable…
The first sentence of the analysis written for AXON on 2026-09-11 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 59.7% | 59.6% | 61.2% | 61.2% | 61.5% | |
| Ebit Margin | 4.1% | 18.7% | 10.5% | 16.5% | -16.4% | |
| Ebitda Margin | 7.1% | 21.0% | 11.7% | 19.1% | -13.6% | |
| Operating Profit Margin | -2.2% | 2.8% | 10.2% | 7.8% | -19.3% | |
| Pretax Profit Margin | 0.7% | 18.3% | 10.1% | 16.5% | -16.4% | |
| Continuous Operations Profit Margin | 4.5% | 18.1% | 11.3% | 12.4% | -7.0% | |
| Net Profit Margin | 4.5% | 18.1% | 11.3% | 12.4% | -7.0% | |
| Bottom Line Profit Margin | 4.5% | 18.1% | 11.3% | 12.4% | -7.0% | |
| Current Ratio | 2.526 | 1.369 | 3.143 | 2.996 | 2.651 | |
| Quick Ratio | 2.293 | 1.211 | 2.789 | 2.660 | 2.391 | |
| Solvency Ratio | 0.055 | 0.198 | 0.109 | 0.113 | -0.056 | |
| Cash Ratio | 0.817 | 0.271 | 0.786 | 0.587 | 0.851 | |
| Price To Earnings Ratio | 354.956 | 119.341 | 109.000 | 80.159 | -172.527 | |
| Price To Earnings Growth Ratio | -5.230 | 1.084 | 7.521 | -0.245 | -0.055 | |
| Forward Price To Earnings Growth Ratio | -5.230 | 1.084 | 7.521 | -0.245 | -0.055 | |
| Price To Earnings Diluted Ratio | 376.113 | 123.817 | 110.871 | 81.739 | -172.527 | |
| Price To Earnings Diluted Growth Ratio | -5.487 | 1.168 | 7.502 | -0.253 | -0.055 | |
| Price To Book Ratio | 14.081 | 19.341 | 11.890 | 9.300 | 9.917 | |
| Price To Sales Ratio | 16.427 | 21.617 | 12.281 | 9.914 | 12.036 | |
| Price To Free Cash Flow Ratio | 608.147 | 136.616 | 148.588 | 65.809 | 140.024 | |
| Price To Operating Cash Flow Ratio | 216.052 | 110.255 | 101.271 | 50.121 | 83.474 | |
| Debt To Assets Ratio | 0.273 | 0.313 | 0.208 | 0.249 | 0.012 | |
| Debt To Equity Ratio | 0.589 | 0.602 | 0.441 | 0.561 | 0.020 | |
| Debt To Capital Ratio | 0.371 | 0.376 | 0.306 | 0.359 | 0.019 | |
| Long Term Debt To Capital Ratio | 0.348 | 0.226 | 0.296 | 0.347 | 0.000 | |
| Financial Leverage Ratio | 2.159 | 1.922 | 2.115 | 2.248 | 1.611 | |
| Working Capital Turnover Ratio | 1.942 | 1.850 | 1.101 | 1.257 | 1.219 | |
| Operating Cash Flow Ratio | 0.144 | 0.243 | 0.249 | 0.391 | 0.297 | |
| Operating Cash Flow Sales Ratio | 0.076 | 0.196 | 0.121 | 0.198 | 0.144 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.355 | 0.807 | 0.682 | 0.762 | 0.596 | |
| Debt Service Coverage Ratio | 1.728 | 0.629 | 28.891 | 0.000 | 0.000 | |
| Interest Coverage Ratio | -0.659 | 8.247 | 22.795 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 2.624 | 0.600 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.111 | 0.291 | 0.266 | 0.331 | 6.091 | |
| Capital Expenditure Coverage Ratio | 1.551 | 5.183 | 3.174 | 4.195 | 2.476 | |
| Dividend Paid And Capex Coverage Ratio | 1.551 | 5.183 | 3.174 | 4.195 | 2.476 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 236.126 | 105.178 | 105.136 | 53.395 | -85.870 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 59.7% | ▲0.1% | ▼-1.0% |
| Ebit Margin | 4.1% | ▼-14.6% | ▼-2.6% |
| Ebitda Margin | 7.1% | ▼-13.9% | ▼-2.0% |
| Operating Profit Margin | -2.2% | ▼-5.0% | ▼-2.1% |
| Pretax Profit Margin | 0.7% | ▼-17.6% | ▼-5.2% |
| Continuous Operations Profit Margin | 4.5% | ▼-13.6% | ▼-3.4% |
| Net Profit Margin | 4.5% | ▼-13.6% | ▼-3.4% |
| Bottom Line Profit Margin | 4.5% | ▼-13.6% | ▼-3.4% |
| Current Ratio | 2.526 | ▲1.156 | ▼-0.011 |
| Quick Ratio | 2.293 | ▲1.082 | ▲0.024 |
| Solvency Ratio | 0.055 | ▼-0.143 | ▼-0.028 |
| Cash Ratio | 0.817 | ▲0.546 | ▲0.155 |
| Price To Earnings Ratio | 354.956 | ▲235.615 | ▲256.770 |
| Price To Earnings Growth Ratio | -5.230 | ▼-6.314 | ▼-5.845 |
| Forward Price To Earnings Growth Ratio | -5.230 | ▼-6.314 | ▼-5.845 |
| Price To Earnings Diluted Ratio | 376.113 | ▲252.296 | ▲272.110 |
| Price To Earnings Diluted Growth Ratio | -5.487 | ▼-6.655 | ▼-6.062 |
| Price To Book Ratio | 14.081 | ▼-5.260 | ▲1.175 |
| Price To Sales Ratio | 16.427 | ▼-5.190 | ▲1.972 |
| Price To Free Cash Flow Ratio | 608.147 | ▲471.531 | ▲388.310 |
| Price To Operating Cash Flow Ratio | 216.052 | ▲105.797 | ▲103.818 |
| Debt To Assets Ratio | 0.273 | ▼-0.041 | ▲0.062 |
| Debt To Equity Ratio | 0.589 | ▼-0.013 | ▲0.146 |
| Debt To Capital Ratio | 0.371 | ▼-0.005 | ▲0.085 |
| Long Term Debt To Capital Ratio | 0.348 | ▲0.122 | ▲0.105 |
| Financial Leverage Ratio | 2.159 | ▲0.236 | ▲0.148 |
| Working Capital Turnover Ratio | 1.942 | ▲0.092 | ▲0.468 |
| Operating Cash Flow Ratio | 0.144 | ▼-0.100 | ▼-0.121 |
| Operating Cash Flow Sales Ratio | 0.076 | ▼-0.120 | ▼-0.071 |
| Free Cash Flow Operating Cash Flow Ratio | 0.355 | ▼-0.452 | ▼-0.285 |
| Debt Service Coverage Ratio | 1.728 | ▲1.099 | ▼-4.522 |
| Interest Coverage Ratio | -0.659 | ▼-8.906 | ▼-6.735 |
| Short Term Operating Cash Flow Coverage Ratio | 2.624 | ▲2.023 | ▲1.979 |
| Operating Cash Flow Coverage Ratio | 0.111 | ▼-0.181 | ▼-1.307 |
| Capital Expenditure Coverage Ratio | 1.551 | ▼-3.632 | ▼-1.765 |
| Dividend Paid And Capex Coverage Ratio | 1.551 | ▼-3.632 | ▼-1.765 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 236.126 | ▲130.948 | ▲153.333 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $45.66B | $45.02B | $19.17B | $11.80B | $10.39B | |
| Enterprise value | $46.37B | $45.97B | $19.28B | $12.15B | $10.06B | |
| EV / Sales | 16.68x | 22.07x | 12.35x | 10.21x | 11.65x | |
| EV / Op. cash flow | 219.41x | 112.58x | 101.86x | 51.64x | 80.78x | |
| EV / Free cash flow | 617.58x | 139.49x | 149.46x | 67.80x | 135.50x | |
| EV / EBITDA | 236.13x | 105.18x | 105.14x | 53.40x | -85.87x | |
| Net debt / EBITDA | 3.61x | 2.17x | 0.61x | 1.57x | 2.87x | |
| Current ratio | 2.53x | 1.37x | 3.14x | 3.00x | 2.65x | |
| Income quality | 1.70x | 1.08x | 1.09x | 1.60x | -2.07x | |
| Graham number | $38 | $59 | $34 | $29 | — | |
| Graham net-net | -$14 | -$5 | $3 | -$1 | $4 | |
| Tax burden | 658.3% | 98.8% | 111.9% | 74.9% | 42.5% | |
| Interest burden | 16.8% | 98.2% | 95.7% | 100.0% | 100.0% | |
| Working capital | $2.24B | $619.6M | $1.63B | $1.20B | $691.0M | |
| Invested capital | $4.14B | $1.80B | $1.95B | $1.43B | $888.5M | |
| Return on assets | 1.8% | 8.4% | 5.2% | 5.2% | -3.6% | |
| Operating ROA | -1.1% | 1.5% | 5.1% | 4.1% | -10.9% | |
| Return on tangible assets | 2.3% | 10.6% | 5.3% | 5.3% | -3.7% | |
| Return on equity | 3.9% | 16.2% | 10.9% | 11.6% | -5.7% | |
| Return on invested capital | -1.1% | 1.7% | 6.0% | 3.1% | -5.6% | |
| Return on capital employed | -1.1% | 2.1% | 6.0% | 4.1% | -13.1% | |
| Earnings yield | 0.3% | 0.8% | 0.9% | 1.2% | -0.6% | |
| Free cash flow yield | 0.2% | 0.7% | 0.7% | 1.5% | 0.7% | |
| Capex / Op. cash flow | 64.5% | 19.3% | 31.5% | 23.8% | 40.4% | |
| Capex / Depreciation | 163.8% | 162.7% | 182.7% | 230.1% | 269.0% | |
| Capex / Sales | 4.9% | 3.8% | 3.8% | 4.7% | 5.8% | |
| SG&A / Sales | 37.2% | 35.6% | 31.7% | 33.6% | 58.4% | |
| R&D / Sales | 24.6% | 21.2% | 19.5% | 19.6% | 22.5% | |
| Stock comp / Sales | 22.8% | 18.4% | 8.4% | 8.9% | 35.1% | |
| Intangibles / Total assets | 22.4% | 20.8% | 2.3% | 2.0% | 3.5% | |
| Days sales outstanding | 126d | 160d | 164d | 170d | 212d | |
| Days payables outstanding | 45d | 31d | 40d | 47d | 35d | |
| Operating cycle | 237d | 276d | 326d | 330d | 331d | |
| Cash conversion cycle | 191d | 244d | 287d | 283d | 296d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-05-11 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-03-04 | Jefferson Shreve | Purchase | $15,001 - $50,000 |
| 2025-01-12 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2023-10-23 | Greg Stanton | Sale (Full) | $1,001 - $15,000 |
| 2023-09-25 | Greg Stanton | Purchase | $1,001 - $15,000 |
Recent news
- 2026-09-10 Axon Enterprise, Inc $AXON Shares Acquired by Arizona State Retirement System Arizona State Retirement System grew its holdings in Axon Enterprise, Inc (NASDAQ: AXON) by 7.5% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 21,898 shares of the biotechnology company''s stock after acquiring an additional 1,528 shares during the quarter. Arizona State Retirement
- 2026-09-09 Here''s Why Axon Enterprise (AXON) Fell More Than Broader Market In the latest trading session, Axon Enterprise (AXON) closed at $490, marking a -3.05% move from the previous day.
- 2026-09-09 Stock of the Day: Is this the Bottom for Axon? Axon Enterprise, Inc. (NASDAQ:AXON) shares are trading sideways Wednesday. They have found support at an important price level.
- 2026-09-09 Concurrent Investment Advisors LLC Has $2.74 Million Stock Position in Axon Enterprise, Inc $AXON Concurrent Investment Advisors LLC raised its stake in Axon Enterprise, Inc (NASDAQ: AXON) by 200.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,889 shares of the biotechnology company''s stock after buying an additional 3,260 shares during the quarter.
- 2026-09-08 Axon Enterprise, Inc. (AXON) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript Axon Enterprise, Inc. (AXON) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript
- 2026-09-08 Brokers Suggest Investing in Axon (AXON): Read This Before Placing a Bet Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock''s price, do they really matter?
- 2026-09-08 California State Teachers Retirement System Acquires 64,666,282 Shares of Axon Enterprise, Inc $AXON California State Teachers Retirement System increased its holdings in shares of Axon Enterprise, Inc (NASDAQ: AXON) by 55,955.7% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,781,849 shares of the biotechnology company''s stock after purchasing an additional 64,666,282 shares during the
- 2026-09-04 Why Is Axon (AXON) Up 3% Since Last Earnings Report? Axon (AXON) reported earnings 30 days ago. What''s next for the stock?
- 2026-09-04 Axon''s Connected Devices Unit Fuels Growth: Can It Sustain the Momentum? AXON''s Connected Devices revenues surge 34.6%, fueled by TASER 10, counter-drone equipment and strong international bookings.
- 2026-09-04 Baron SMID Cap ETF Q2 2026 Portfolio Activity During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.